Bionovate Technologies Corp
BIIO · OTC
6/30/2021 | 6/30/2020 | 6/30/2019 | 6/30/2018 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.00 | -0.00 |
| FCF Yield | -550.88% | 408.07% | -27,162.81% | -42,610,685.94% |
| EV / EBITDA | -5.23 | -5.61 | -633.34 | 0.00 |
| Quality | ||||
| ROIC | 17.07% | 15.64% | 38.05% | 293.48% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.00 | -0.00 | 0.00 | 0.86 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | -100.00% | -100.00% |
| Free Cash Flow Growth | -331.37% | 134.93% | 99.98% | -14,276.77% |
| Safety | ||||
| Net Debt / EBITDA | -5.23 | -5.61 | -633.34 | 0.00 |
| Interest Coverage | -0.74 | -0.37 | -0.37 | -1.76 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |